Pediatric nephrotic syndrome is a prevalent glomerular disease that presents in children as either steroid sensitive or steroid resistant, depending on whether complete remission is achieved following corticosteroid treatment. A new mini-review published in Pediatric Research highlights the urgent need for clinically actionable tools that can identify steroid resistant nephrotic syndrome at disease onset. Currently, steroid resistant nephrotic syndrome is diagnosed only after a failed six-week steroid trial, a process that exposes children to significant adverse effects. The review emphasizes that early identification is critical because steroid resistant nephrotic syndrome confers an increased risk of progression to kidney failure, prompting the need for early personalized treatment and risk stratification.
The distinction between immune-mediated and monogenic forms of the disease is central to therapeutic decision-making. Immune-mediated steroid resistant nephrotic syndrome may respond to intensified immunosuppression, whereas monogenic forms are typically multidrug-resistant. For these monogenic cases, it is essential to avoid ineffective therapies and implement targeted management strategies earlier. The review argues that advances in genetics offer the potential to predict steroid resistance at presentation, enabling a paradigm shift toward personalized care.
Established clinical diagnostics such as whole-exome and whole-genome sequencing are increasingly complemented by emerging research tools. These emerging approaches include genome-wide association studies, epigenetic profiling, proteomics, microRNA analysis, and polygenic risk scores. However, the review notes that these tools remain largely investigational and are not yet routinely implemented in clinical practice. The article highlights current and emerging genetic approaches for early nephrotic syndrome stratification and analyzes their clinical applicability. The goal is to develop methods that can differentiate steroid resistant from steroid sensitive cases before the trial of corticosteroids begins.
The review analyzes key podocyte genes that are central to the pathogenesis of nephrotic syndrome, specifically NPHS1, NPHS2, and WT1. NPHS1 biallelic pathogenic variants are identified as the main cause of congenital nephrotic syndrome, particularly in Finnish populations. In contrast, NPHS2 mutations mostly underlie early steroid resistant nephrotic syndrome onset. Monoallelic WT1 mutations cause both isolated and syndromic forms of steroid resistant nephrotic syndrome. Patients with WT1 mutations necessitate oncologic surveillance due to associated risks. Understanding the specific genetic variant is crucial for accurate prognosis and therapeutic planning.
Accurate variant interpretation is essential for prognosis, therapeutic decision-making, and genetic counseling. The review discusses the complexity of the testing process, illustrated by a diagnostic algorithm for genetic testing in nephrotic syndrome. A decision framework is also presented for the systematic approach to reclassifying a Variant of Uncertain Significance.
The article also discusses the emerging role of non-invasive biomarkers and epigenetic mechanisms in distinguishing steroid resistant from steroid sensitive nephrotic syndrome. These mechanisms may help predict disease progression without the need for invasive procedures.
Subject of Research: Genetic diagnostic methods for pediatric nephrotic syndrome
Article Title: Pediatric nephrotic syndrome: a mini-review of genetic diagnostic methods
Article References: Sathik, N., Parashar, S., Grden, A., Hu, J., Datta, D., Sinha, R., Chan, E. Y.-H., Boyer, O., & Raina, R. (2026). Pediatric nephrotic syndrome: a mini-review of genetic diagnostic methods. Pediatric Research. https://doi.org/10.1038/s41390-026-05473-8
Image Credits: AI Generated
DOI: 10.1038/s41390-026-05473-8
Keywords: Pediatric Nephrotic Syndrome, Genetic Diagnostics, Steroid Resistance, Whole-Exome Sequencing, NPHS1, NPHS2, WT1, Precision Medicine, Pediatric Research, Glomerular Disease, Pediatric, nephrotic
News Source: Juliet Wilcox. (November 10, 2026). Genetic Tools Aim to Predict Steroid Resistance in Children. Scienmag.



